Home » Topics » Regulatory » Patents

Patents
RSS

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Novel diagnostic agents for spongiform encephalopathies reported

Dec. 9, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

RPR continues research into taxanes

Dec. 5, 1996

Schering-Plough continues research into FPTase inhibitors

Dec. 4, 1996

New bisphosphonic acid derivatives from Nippon Chemiphar

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.